Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Raul Prytog who wrote (10228)	5/27/1999 5:43:00 PM
From: aknahow	Read Replies (4) \| Respond to of 17367

There are logical reasons to be fairly sure. When your kid is dying do you say no to a chance to help? Do you care if it is a big chance or not? Or you have a kidney stone or anything else that requires you to sign a release saying you understand that the treatment might kill you, because of the pain you sign on the dotted line. so I do not see too many people refusing. Since these 62 were about to be enrolled we "know" they qualified as to other aspects of the trial. We know there were not 622 that would have qualified but somehow did not get into the trial since every effort was being made to get subjects into the trial. And we have phls statistics on the number of actual cases in the U.K. What I am saying is I personally have a high level of confidence that children with >8 or higher that got to participating hospitals and had no other cause for non enrollment probably were enrolled to a very high degree. The 62 referred to were at participating hospitals. Can't make a logical case for 62 that were 8 or above not being enrolled in the trial. Parents or guardians were given a choice of stand care or something extra and probably some information on the safety profile of the something else. At any rate it would be interesting to eventually see actual statistics on how many were against allowing participation in the trial. Death and the nature of this disease are powerful motivators to sign up for anything.